Phase I 01910.Na Infusion w/Leukemia or Myelodyspastic MDS
ID Number 02-0587-00003Principal Investigator(s)
Lewis R. Silverman
Department(s) or Division(s)
Hematology and Medical Oncology
The purpose of this study is determine the safety of the study drug ON 01910.Na, which is an investigational drug that has not been approved by the United States Food and Drug Administration (FDA). Patients may qualify for participation in this study if (1) they have a diagnosis of a leukemia; acute myelocytic leukemia (AML); acute lymphocytic leukemia (ALL); chronic myelocytic leukemia (CML); chronic lymphocytic leukemia (CLL); or myelodysplastic syndrome (MDS), and (2) they have a disease which cannot be cured with known treatments and for which no other therapy is known to be consistently effective.
Recruiting Patients: Yes